Category - New Drugs
FDA Approves Lynparza (olaparib tablets) for Germline BRCA-Mutated Metastatic Breast Cancer
GSK Receives FDA Approval for Expanded Indication for Fluarix Quadrivalent (Influenza Vaccine) for Persons 6 Months and Older
FDA Approves Xgeva (denosumab) for the Prevention of Skeletal-Related Events in Patients with Multiple Myeloma
Bausch + Lomb Receives FDA Approval of Lumify (brimonidine tartrate) Over-the-Counter Eye Drop for the Treatment of Eye Redness
FDA Approves Segluromet (ertugliflozin and metformin hydrochloride) for Type 2 Diabetes
FDA Approves Steglujan (ertugliflozin and sitagliptin) for Type 2 Diabetes
FDA Approves Steglatro (ertugliflozin) for Type 2 Diabetes
FDA Updates the Label of Tasigna to Reflect that Certain Patients with a Type of Leukemia May be Eligible to Stop Treatment After Sustained Response